DNA/RNA Hybrid-Based Fluorescent Probe Enabled One-Step Detection of the Subcellular Activities of Human Apurinic/Apyrimidinic Endonuclease 1

Peng Lü,Xiang‐Jian Cao,Chenxu Zhu,Ying Sun,Ruilan Zhang,Wenlong Yang,Jinghui Zheng,Zi-Yu Tang,Jiayu Wang,Meiping Zhao

DOI: https://doi.org/10.2139/ssrn.4281496

2022-01-01

SSRN Electronic Journal

Abstract:As a key DNA repair enzyme, human apurinic/apyrimidinic endonuclease 1 (APE1) participates in many crucial cellular processes. It has been recognized as a potential prognostic biomarker and a therapeutic target for many cancer and other diseases. However, no methods are available now for direct quantification of the APE1 activity in subcellular compartments without tedious pre-isolation steps because of the intensive cellular background. In this work, we report a DNA/RNA hybrid-based fluorescent probe which enabled one-step detection of APE1 in the nuclear, cytoplasmic, and mitochondrial extracts of different types of cultured cells without the need of any purification steps. With the noncanonical structure, the hybrid probe showed an exquisite specificity for APE1 and strong resistance against other nucleases. Taking advantage of a substantial acceleration effect of the 3’-flanking mismatches on the reaction rates, the hybrid probe showed high sensitivity to the target enzyme (linear working range: 0.02~1.0 U/mL; detection limit: 0.01 U/mL). The mechanism for the rapid digestion of the modified structure by APE1 was clarified via kinetic study and single-molecule fluorescence resonance energy transfer (smFRET) analysis. Significantly varied subcellular distribution of APE1 in different cells were observed by using the probe. The method was simple and robust, which offered an easily accessible molecular tool for high-throughput quantification of the subcellular APE1 activity. It may also facilitate the development of effective APE1-targeted inhibitors as anticancer drugs.